| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 257,995 | 256,619 | 254,995 | 236,743 | | Cost of Revenue | 56,736 | 57,476 | 60,308 | 58,632 | | | Gross Profit | 201,259 | 199,143 | 194,687 | 178,111 | | | Operating Expenses | | Research Development | 24,940 | 23,234 | 24,802 | 19,419 | | Selling General and Administrative | 87,649 | 88,238 | 87,175 | 85,760 | | Non Recurring | 10,428 | 470 | 4,775 | 81,185 | | Others | 3,112 | 3,061 | 3,221 | 1,446 | | | | Total Operating Expenses | 126,129 | 115,003 | 119,973 | 187,810 | | | | Operating Income or Loss | 75,130 | 84,140 | 74,714 | (9,699) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (32,279) | 1,539 | 7,512 | 42,002 | | Earnings Before Interest And Taxes | 42,851 | 85,679 | 82,226 | 32,303 | | Interest Expense | (23,610) | 11,805 | 11,805 | (30,578) | | Income Before Tax | 66,461 | 73,874 | 70,421 | 62,881 | | Income Tax Expense | 18,111 | 29,570 | 23,532 | 36,158 | | Minority Interest | (2,381) |
-
|
-
| 18,719 | | | | Net Income From Continuing Ops | 48,350 | 44,304 | 46,889 | 44,673 | | | Non-recurring Events | | Discontinued Operations | 6,249 | (8,532) | 18,626 | (145,184) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 52,218 | 35,772 | 65,515 | (100,511) | | Preferred Stock And Other Adjustments | 1,393 | (898) | (495) |
-
| | | Net Income Applicable To Common Shares | $53,611 | $34,874 | $65,020 | ($100,511) |
|
1.52% Nasdaq 0.00%
Income Statement
